Global Bio-chem revenue rises but profit slumps on one-off comparisons

The latest announcement is out from Global Bio-chem Technology Group Co. Ltd. ( (HK:0809) ).

Global Bio-chem Technology Group Company Limited reported a rise in revenue to HK$2.28 billion for the year ended 31 December 2025, up from HK$2.00 billion a year earlier, driven by its corn-based biochemical operations. The group generated gross profit of HK$196.4 million and substantially higher other income and gains, while reducing administrative expenses and recording lower finance costs compared with the prior year.

Despite these improvements, profit before tax fell sharply to HK$156.4 million from HK$745.6 million, mainly due to the absence of the prior-year gain on disposal of subsidiaries and the recognition of impairment on amounts due from former subsidiaries. Net profit dropped to HK$156.3 million from HK$769.6 million, and total comprehensive income declined to HK$45.5 million as foreign exchange losses weighed on results, leading to a reduction in both basic and diluted earnings per share, which may temper investor sentiment despite underlying operational stability.

The most recent analyst rating on (HK:0809) stock is a Sell with a HK$0.06 price target. To see the full list of analyst forecasts on Global Bio-chem Technology Group Co. Ltd. stock, see the HK:0809 Stock Forecast page.

More about Global Bio-chem Technology Group Co. Ltd.

Global Bio-chem Technology Group Company Limited is a Hong Kong-listed company incorporated in the Cayman Islands that operates in the biochemical and agricultural processing sector. The group focuses on producing and selling corn-based biochemical products and related derivatives, serving industrial and consumer markets primarily in China and other international regions.

Average Trading Volume: 4,945,762

Technical Sentiment Signal: Sell

Current Market Cap: HK$1.01B

For a thorough assessment of 0809 stock, go to TipRanks’ Stock Analysis page.